Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Licitra

Showing results (61-70 of 101) with videos related to

Pageof 11
Sort By:
European Journal of Cancer (Oxford, England : 1990)|June 4, 2013
Phase II study of pemetrexed in combination with cisplatin and cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neckJ B Vermorken, L Licitra, J Stöhlmacher-Williams, et al.
ESMO Open|March 15, 2025
Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide in head and neck cancer: the CONFRONT phase I-II trialM C Merlano, N Denaro, M Paccagnella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancerL Licitra, L D Locati, R Cavina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2004
Prediction of TP53 status for primary cisplatin, fluorouracil, and leucovorin chemotherapy in ethmoid sinus intestinal-type adenocarcinomaL Licitra, S Suardi, P Bossi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2014
Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysisP Bossi, E Orlandi, R Miceli, et al.
European Journal of Cancer (Oxford, England : 1990)|September 30, 2008
Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982)C M L van Herpen, L D Locati, J Buter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 5, 2010
Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME studyL Licitra, R Mesia, F Rivera, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 19, 2011
T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical resultsS Secondino, M Zecca, L Licitra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 28, 2020
Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>†</sup>P Bossi, A T Chan, L Licitra, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 21, 2015
Italian version of the M.D. Anderson Symptom Inventory--Head and Neck Module: linguistic validationA Greco, E Orlandi, A Mirabile, et al.
Pageof 11

Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
European Journal of Cancer (Oxford, England : 1990)|June 4, 2013
Phase II study of pemetrexed in combination with cisplatin and cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neckJ B Vermorken, L Licitra, J Stöhlmacher-Williams, et al.
ESMO Open|March 15, 2025
Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide in head and neck cancer: the CONFRONT phase I-II trialM C Merlano, N Denaro, M Paccagnella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancerL Licitra, L D Locati, R Cavina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2004
Prediction of TP53 status for primary cisplatin, fluorouracil, and leucovorin chemotherapy in ethmoid sinus intestinal-type adenocarcinomaL Licitra, S Suardi, P Bossi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2014
Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysisP Bossi, E Orlandi, R Miceli, et al.
European Journal of Cancer (Oxford, England : 1990)|September 30, 2008
Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982)C M L van Herpen, L D Locati, J Buter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 5, 2010
Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME studyL Licitra, R Mesia, F Rivera, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 19, 2011
T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical resultsS Secondino, M Zecca, L Licitra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 28, 2020
Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>†</sup>P Bossi, A T Chan, L Licitra, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 21, 2015
Italian version of the M.D. Anderson Symptom Inventory--Head and Neck Module: linguistic validationA Greco, E Orlandi, A Mirabile, et al.
Pageof 11